Proporsi Kandidiasis Kutis Pada Pasien Diabetes Melitus Tipe 2 Berdasarkan Kadar Hemoglobin Glikosilat (Hba1c) Di Rumah Sakit Umum Pusat Haji Adam Malik Medan
DAFTAR PUSTAKA
1. Verma S, Heffernan MP. Superficial fungal infection. In: Wolf K,
Goldsmith LA, Katz SI, Gilchesrt BA, Paller AS, Leffell DJ, editors.
Fitzpatrick’sDermatology In General Medicine.7 thed. New York:
McGraw-Hill Companies Inc, 2008.p.1807-44
2. Eckhard M, Lenger A, Liersch J, Bretzel RG, Mayser P. Fungal foot
infection in patients with diabetes mellitus-results of two independent
investigations. Mycoses 2007; 50 (2): 14-9.
3. Bristow I. Non-ulserative skin pathologies of diabetic foot. Diabetes
Metab Res Rev 2008; 24(Suppl 1): S84–9
4. Roderick J. The management of superficial candidiasis. Journal of the
American academy of dermatology 1999; 40: 35-42
5. Fony WA, Calderon RA. Virulence factors of candida albicans. Trends in
microbiology 2001; 9: 327-35
6. Samaranayake LP, Jayatilake JAMS. Experimental superficial candidiasis
on tissue models. Micoses 2010; 53: 285-95
7. Mujtaba G, Saifullah. Diabetic’s skin; a storehouse of infection. Journal
of Pakistan association of dermatologists 2009; 19: 34-7
8. Davis JD. Superficial fungal infection of the skin: tinea corporis, tinea
pedis, and candida intertrigo. Infectious diseases update 1995; 2: 157-61
9. Goodall
I.HbA1c
Standardisation
destination—global
IFCC
standardisation how, why, where and when. Clin Biochem Rev 2005; 26
(1).
10. Ragunatha S, Anitha B, Inamadar C, Palit A, Devarmani SS. Cutaneus
disorders in 500 patients attending diabetic clinic. Indian J Dermatol 2011;
56: 2-6
11. Suheyla S. The frequency of superficial fungal infection in patients with
diabetes mellitus and its relation to the level of HbA1c. Turkish J
Endocrinol Metab 1998; 2: 21-3
12. Perkumpulan Endokrinologi Indonesia. Dalam: Konsensus pengelolaan
dan pencegahan diabetes melitus tipe 2 di Indonesia. Jakarta: PB
PERKENI; 2008. h. 4-27.
13. Mahler RJ, Adler ML. Type 2 diabetes mellitus : Update on diagnosis,
pathophysiology, and treatment. jcem.endojournals. 1999; 84: 1165-71.
14. Jahangir MU, Ahmed I, Nasreen S. Cutaneous manifestations of diabetic
foot. Jornal of Pakistan association of dermatologysts 2009; 19: 13-7
15. Wani MA, Hassan I, Hayat BM, Ahmed QM. Cutaneus manifestation of
diabetes mellitus : A hospital based study in Kashmir, India. Edog 2009;
5(2).
16. Nasreen S, Ahmaed I, Jahangir M. Cutaneous manifestations of diabetic
foot. Journal of Pakistan Association of dermatologists 2009; 19: 13-7
17. Ahmed K, Muhammad Z, Qayum I. Prevalence of cutaneus manifestaion
of diabetes mellitus. J Ayub Med Coll Abbottabad 2009; 2: 76
18. Akbar N, Bilal N. The sweet foot relation of glycemic control with
diabetic foot lesion. International journal of pathology 2004; 2(2): 90-3
19. Kusniyah Y, Nursiswati, Rahayu U. Hubungan tingkat self care dengan
tingkat HbA1c pada klien diabetes melitus tipe-2 di poliklinik endokrin
RSUP dr. Hasan Sadikin Bandung. Pustaka UNPAD 2010.
20. Somerville DA, Marples MJ. The oral and cutaneous distribution of
candida albicans and other yeasts in rarotonga, cook island. Transactions
of the royal society of tropical medicine and hygiene 1968; 2 : 256-62
21. Sohnle PG, Wilson BD. Neutrophil Accumulation and cutaneous
responses in experimental cutaneus candidiasis of genetically complement
deficient mice. Clinical immunology and immunopathology 1988; 46:
284-93
22. Vyas.SP, Gupta M. Development, characterization and in vivo assessment
of effective lipidic nanoparticles for dermal delivery of fluconaole against
cutaneous candidiasis. Chemestry and physics of lipids 2012; 165: 454-61
23. Hay RJ, Moore J. Mycology. In : Burn T, Breathnach S, Cox N, editor.
Rook’s Text Book of Dermatology.7th ed. Black-Well; 2004: p. 1425-7
24. Sohnle PG, Wilson BD. Neutrophil Accumulation and cutaneous
responses in experimental cutaneus candidiasis of genetically complement
deficient mice. Clinical immunology and immunopathology 1988; 46:
284-93
25. Madiyono B, Moeslichan S, Sastroasmoro S, Budiman I, Purwanto SH.
Perkiraan besar sample. Dalam : Sastroasmoro S, Ismael S, editor. Dasardasar Metodologi Penelitian Klinis. Edisi ke-3. Jakarta : Sagung Seto
2008; h. 302-30
26. Drozdowska A, Drzewoski J. Mycoses in diabetes—Difficult diagnostic
and therapeutic problem. Viamedica 2008; 8(1): 1-11
27. Hay R. Superficial fungal infection. Skin and soft tissue infection 2005:
89-90
28. Havlickova B, Czaika VA, Friedrich M. Epidemiological trends in skin
mycoses worldwide. Mycoses 2008; 51 (4): 2-15
29. Ryan K. Characteristics of fungi. In : Ryan KJ, Ray GG, editors. Sherris
Medical Microbiology an introduction of infection disease. 4 th ed. United
State of America: The McGraw-Hill Companies Inc, 2004.p. 631-8
30. Brasch J. Pathogenesis of tinea. J Dtsch Dermatol Ges 2010; 8(10): 780-6
31. Romani L. Immunity to fungal infections. Nat Rev Immunol 2011; 11(4):
275-88
32. Speth C, Rambach G, Wurzner, Florl CL. Complement and fungal
pathogens : up date. Mycoses 2008; 51: 477-96
33. Friedlander SF, Aly R, Krafchik B, Blumer J, Honig P . Terbinafine in the
treatment of trichophyton tinea capitis : A randomized, double-blind,
parallel-group, duration-finding study. PEDIATRICS 2002; 109(4): 602-7
34. Soto RM, Galimberti R, Suchil. Fluconazole versus ketokonazole in the
treatment of dermatophytoses and cutaneous candidiasis. International
journal of dermatology 1994; 33(10): 726-8
35. Mansour AA. Chronic complication of diabetes in Iraq : Experience from
Southern Iraq. Clinical Medicine Endocrinology and Diabetes 2009; 2: 19
36. Manaf A. Thiazolidinediones : Their role in the blood glucose and lipid
control in prediabetes and diabetes. Malang: PB PERKENI ; 2007
37. Szypowska A. Fungal infection in diabetes. DiabetesmResearch and
Clinical Practice 2007; 86 (1): 31-6
38. McManus LM, Bloodworth RC, Prihoda TJ, Blodgett JL, Pinckard RN.
Agonist- dependent failur of neutrofil function in diabetes correlates with
extent of hyperglycemia. J Leukocyte Biol 2001; 70: 395-404
39. Peleg AY, Weerarathna T, McCarthy JS, Davis TME. Common infections
in diabetes : pathogenesis, management and relationhip to glycaemic
control. Diabetes Metab Res Rev 2007; 23: 3-13
40. Boyko EJ, Ahroni JH, Cohen V, Nelson KM, Haegerty PJ. Prediction of
diabetic foot ulcer occurrence using commonly available clinical
information. Diabetes Care 2006; 29: 1202-7
41. Powers CA. Diabetes Mellitus. In : Kasper DL, Braunwald E, Fauci AS,
Hauser SL, Longo DN, Jameson JL, editors. Harrison’s Principles of
Internal Medicine. 16thed. New York : McGraw-Hill Companies Inc,
2005.p. 2152-85
42. Badan Penelitian dan Pengembangan Kesehatan Departemen Kesehatan
Republik Indonesia. Riset Kesehatan Dasar 2007. Jakarta : Departemen
kesehatan RI; 2008
43. Ragunatha S, Anitha B, Inamadar C, Palit A, Devarmani SS. Cutaneus
disorders in 500 patients attending diabetic clinic. Indian J Dermatol 2011;
56: 2-6
44. Suryaatmaja M. Standarisasi dan harmonisasi pemeriksaan HbA1c.
Dalam: Pendidikan berkesinambungan Patologi klinik 2010. Jakarta:
Balai Penerbit FK UI; 2010. h.92-104
45. Harefa E. Dalam : Peran HbA1c dalam skrining dan diagnosis diabetes.
Jakarta: Forum Diagnostikum; 2010.h. 3-7
46. Timshina DK, Thappa DM, Agrawal A. A clinical study of dermatoses in
diabetes to establish its marker. Indian J Dermatol 2012; 57(1): 20-7
47. Kafaie P, Noorbala MT. Evaluation of onychomycosis among diabetic
patients of yeast diabetic center. Journal of Pakistan Association of
Dermatologists 2010; 20: 217-22
48. Romano G, Morreti G, Di Benedetto A, Giofre C, Di Cesare E, Russo G,
et al. Skin lesions in diabetes mellitus : prevalence and clinical
correlations. Diabetes Res Clin Pract 1998; 39(2): 101-6
49. Ching-Hong PV. Infection in patients diabetes mellitus : importance of
early recognitions, treatment, and preventions. Adv Stud Med 2006; 6(2):
71-81
50. Lugo-Somolinos A, Sanchez JL. Prevalence of dermatophytosis in
patients with diabetes. J Am Acad Dermatol 1992; 26: 408
1. Verma S, Heffernan MP. Superficial fungal infection. In: Wolf K,
Goldsmith LA, Katz SI, Gilchesrt BA, Paller AS, Leffell DJ, editors.
Fitzpatrick’sDermatology In General Medicine.7 thed. New York:
McGraw-Hill Companies Inc, 2008.p.1807-44
2. Eckhard M, Lenger A, Liersch J, Bretzel RG, Mayser P. Fungal foot
infection in patients with diabetes mellitus-results of two independent
investigations. Mycoses 2007; 50 (2): 14-9.
3. Bristow I. Non-ulserative skin pathologies of diabetic foot. Diabetes
Metab Res Rev 2008; 24(Suppl 1): S84–9
4. Roderick J. The management of superficial candidiasis. Journal of the
American academy of dermatology 1999; 40: 35-42
5. Fony WA, Calderon RA. Virulence factors of candida albicans. Trends in
microbiology 2001; 9: 327-35
6. Samaranayake LP, Jayatilake JAMS. Experimental superficial candidiasis
on tissue models. Micoses 2010; 53: 285-95
7. Mujtaba G, Saifullah. Diabetic’s skin; a storehouse of infection. Journal
of Pakistan association of dermatologists 2009; 19: 34-7
8. Davis JD. Superficial fungal infection of the skin: tinea corporis, tinea
pedis, and candida intertrigo. Infectious diseases update 1995; 2: 157-61
9. Goodall
I.HbA1c
Standardisation
destination—global
IFCC
standardisation how, why, where and when. Clin Biochem Rev 2005; 26
(1).
10. Ragunatha S, Anitha B, Inamadar C, Palit A, Devarmani SS. Cutaneus
disorders in 500 patients attending diabetic clinic. Indian J Dermatol 2011;
56: 2-6
11. Suheyla S. The frequency of superficial fungal infection in patients with
diabetes mellitus and its relation to the level of HbA1c. Turkish J
Endocrinol Metab 1998; 2: 21-3
12. Perkumpulan Endokrinologi Indonesia. Dalam: Konsensus pengelolaan
dan pencegahan diabetes melitus tipe 2 di Indonesia. Jakarta: PB
PERKENI; 2008. h. 4-27.
13. Mahler RJ, Adler ML. Type 2 diabetes mellitus : Update on diagnosis,
pathophysiology, and treatment. jcem.endojournals. 1999; 84: 1165-71.
14. Jahangir MU, Ahmed I, Nasreen S. Cutaneous manifestations of diabetic
foot. Jornal of Pakistan association of dermatologysts 2009; 19: 13-7
15. Wani MA, Hassan I, Hayat BM, Ahmed QM. Cutaneus manifestation of
diabetes mellitus : A hospital based study in Kashmir, India. Edog 2009;
5(2).
16. Nasreen S, Ahmaed I, Jahangir M. Cutaneous manifestations of diabetic
foot. Journal of Pakistan Association of dermatologists 2009; 19: 13-7
17. Ahmed K, Muhammad Z, Qayum I. Prevalence of cutaneus manifestaion
of diabetes mellitus. J Ayub Med Coll Abbottabad 2009; 2: 76
18. Akbar N, Bilal N. The sweet foot relation of glycemic control with
diabetic foot lesion. International journal of pathology 2004; 2(2): 90-3
19. Kusniyah Y, Nursiswati, Rahayu U. Hubungan tingkat self care dengan
tingkat HbA1c pada klien diabetes melitus tipe-2 di poliklinik endokrin
RSUP dr. Hasan Sadikin Bandung. Pustaka UNPAD 2010.
20. Somerville DA, Marples MJ. The oral and cutaneous distribution of
candida albicans and other yeasts in rarotonga, cook island. Transactions
of the royal society of tropical medicine and hygiene 1968; 2 : 256-62
21. Sohnle PG, Wilson BD. Neutrophil Accumulation and cutaneous
responses in experimental cutaneus candidiasis of genetically complement
deficient mice. Clinical immunology and immunopathology 1988; 46:
284-93
22. Vyas.SP, Gupta M. Development, characterization and in vivo assessment
of effective lipidic nanoparticles for dermal delivery of fluconaole against
cutaneous candidiasis. Chemestry and physics of lipids 2012; 165: 454-61
23. Hay RJ, Moore J. Mycology. In : Burn T, Breathnach S, Cox N, editor.
Rook’s Text Book of Dermatology.7th ed. Black-Well; 2004: p. 1425-7
24. Sohnle PG, Wilson BD. Neutrophil Accumulation and cutaneous
responses in experimental cutaneus candidiasis of genetically complement
deficient mice. Clinical immunology and immunopathology 1988; 46:
284-93
25. Madiyono B, Moeslichan S, Sastroasmoro S, Budiman I, Purwanto SH.
Perkiraan besar sample. Dalam : Sastroasmoro S, Ismael S, editor. Dasardasar Metodologi Penelitian Klinis. Edisi ke-3. Jakarta : Sagung Seto
2008; h. 302-30
26. Drozdowska A, Drzewoski J. Mycoses in diabetes—Difficult diagnostic
and therapeutic problem. Viamedica 2008; 8(1): 1-11
27. Hay R. Superficial fungal infection. Skin and soft tissue infection 2005:
89-90
28. Havlickova B, Czaika VA, Friedrich M. Epidemiological trends in skin
mycoses worldwide. Mycoses 2008; 51 (4): 2-15
29. Ryan K. Characteristics of fungi. In : Ryan KJ, Ray GG, editors. Sherris
Medical Microbiology an introduction of infection disease. 4 th ed. United
State of America: The McGraw-Hill Companies Inc, 2004.p. 631-8
30. Brasch J. Pathogenesis of tinea. J Dtsch Dermatol Ges 2010; 8(10): 780-6
31. Romani L. Immunity to fungal infections. Nat Rev Immunol 2011; 11(4):
275-88
32. Speth C, Rambach G, Wurzner, Florl CL. Complement and fungal
pathogens : up date. Mycoses 2008; 51: 477-96
33. Friedlander SF, Aly R, Krafchik B, Blumer J, Honig P . Terbinafine in the
treatment of trichophyton tinea capitis : A randomized, double-blind,
parallel-group, duration-finding study. PEDIATRICS 2002; 109(4): 602-7
34. Soto RM, Galimberti R, Suchil. Fluconazole versus ketokonazole in the
treatment of dermatophytoses and cutaneous candidiasis. International
journal of dermatology 1994; 33(10): 726-8
35. Mansour AA. Chronic complication of diabetes in Iraq : Experience from
Southern Iraq. Clinical Medicine Endocrinology and Diabetes 2009; 2: 19
36. Manaf A. Thiazolidinediones : Their role in the blood glucose and lipid
control in prediabetes and diabetes. Malang: PB PERKENI ; 2007
37. Szypowska A. Fungal infection in diabetes. DiabetesmResearch and
Clinical Practice 2007; 86 (1): 31-6
38. McManus LM, Bloodworth RC, Prihoda TJ, Blodgett JL, Pinckard RN.
Agonist- dependent failur of neutrofil function in diabetes correlates with
extent of hyperglycemia. J Leukocyte Biol 2001; 70: 395-404
39. Peleg AY, Weerarathna T, McCarthy JS, Davis TME. Common infections
in diabetes : pathogenesis, management and relationhip to glycaemic
control. Diabetes Metab Res Rev 2007; 23: 3-13
40. Boyko EJ, Ahroni JH, Cohen V, Nelson KM, Haegerty PJ. Prediction of
diabetic foot ulcer occurrence using commonly available clinical
information. Diabetes Care 2006; 29: 1202-7
41. Powers CA. Diabetes Mellitus. In : Kasper DL, Braunwald E, Fauci AS,
Hauser SL, Longo DN, Jameson JL, editors. Harrison’s Principles of
Internal Medicine. 16thed. New York : McGraw-Hill Companies Inc,
2005.p. 2152-85
42. Badan Penelitian dan Pengembangan Kesehatan Departemen Kesehatan
Republik Indonesia. Riset Kesehatan Dasar 2007. Jakarta : Departemen
kesehatan RI; 2008
43. Ragunatha S, Anitha B, Inamadar C, Palit A, Devarmani SS. Cutaneus
disorders in 500 patients attending diabetic clinic. Indian J Dermatol 2011;
56: 2-6
44. Suryaatmaja M. Standarisasi dan harmonisasi pemeriksaan HbA1c.
Dalam: Pendidikan berkesinambungan Patologi klinik 2010. Jakarta:
Balai Penerbit FK UI; 2010. h.92-104
45. Harefa E. Dalam : Peran HbA1c dalam skrining dan diagnosis diabetes.
Jakarta: Forum Diagnostikum; 2010.h. 3-7
46. Timshina DK, Thappa DM, Agrawal A. A clinical study of dermatoses in
diabetes to establish its marker. Indian J Dermatol 2012; 57(1): 20-7
47. Kafaie P, Noorbala MT. Evaluation of onychomycosis among diabetic
patients of yeast diabetic center. Journal of Pakistan Association of
Dermatologists 2010; 20: 217-22
48. Romano G, Morreti G, Di Benedetto A, Giofre C, Di Cesare E, Russo G,
et al. Skin lesions in diabetes mellitus : prevalence and clinical
correlations. Diabetes Res Clin Pract 1998; 39(2): 101-6
49. Ching-Hong PV. Infection in patients diabetes mellitus : importance of
early recognitions, treatment, and preventions. Adv Stud Med 2006; 6(2):
71-81
50. Lugo-Somolinos A, Sanchez JL. Prevalence of dermatophytosis in
patients with diabetes. J Am Acad Dermatol 1992; 26: 408